Exogenous rhTRX reduces lipid accumulation under LPS-induced inflammation

Area of Science:

• Biochemistry
• Immunology
• Dermatology

Background:

• Inflammation involves complex redox regulation and protein expression changes.
• Lipopolysaccharide (LPS) is a potent inducer of inflammatory responses.
• Thioredoxin system proteins play crucial roles in cellular redox homeostasis.

Purpose of the Study:

• To investigate the anti-inflammatory and anti-oxidative effects of recombinant human thioredoxin (rhTRX).
• To identify protein expression changes associated with LPS-induced inflammation and rhTRX treatment.
• To evaluate the therapeutic potential of rhTRX in skin inflammation models.

Main Methods:

• Proteomic analysis (2-DE) of A375 cells treated with LPS and rhTRX.
• Quantification of cytokines in vivo using cytometry bead array.
• Measurement of reactive oxygen intermediates (ROI) and nitric oxide (NO) production.

Main Results:

• Exogenous rhTRX inhibited LPS-stimulated ROI and NO production.
• rhTRX modulated intracellular protein levels, including TIP47 and ATP synthase, affecting lipid metabolism.
• rhTRX downregulated inflammatory cytokines in vivo, demonstrating anti-inflammatory effects.

Conclusions:

• Exogenous rhTRX exhibits significant anti-inflammatory and anti-oxidative properties.
• rhTRX modulates redox environments and lipid metabolism during inflammation.
• rhTRX holds therapeutic promise for treating skin inflammation.